Elafibranor, an Agonist of the Peroxisome Proliferator−Activated Receptor−α and −δ, Induces Resolution of Nonalcoholic Steatohepatitis Without Fibrosis WorseningVlad Ratziu, Velimir A. Luketic, Juan F. Gallegos‐Orozco et al.|Gastroenterology|2016Cited by 1k
A Placebo-Controlled Trial of Bezafibrate in Primary Biliary CholangitisChristophe Corpechot, Raoul Poupon, Olivier Chazouillères et al.|New England Journal of Medicine|2018Cited by 605
Purification and characterization of six cytochrome P-450 isozymes from human liver microsomesPhilip P. Wang, F. Peter Guengerich, Philippe Beaune et al.|Biochemistry|1983Cited by 192
66 SILEN-C2: SUSTAINED VIROLOGIC RESPONSE (SVR) AND SAFETY OF BI201335 COMBINED WITH PEGINTERFERON ALFA-2A AND RIBAVIRIN (P/R) IN CHRONIC HCV GENOTYPE-1 PATIENTS WITH NON-RESPONSE TO P/RMark Sulkowski, Gerhard Steinmann, Marc Bourlière et al.|Journal of Hepatology|2011Cited by 30